Interleukin-22 Suppresses the Growth of A498 Renal Cell Carcinoma Cells via Regulation of STAT1 Pathway

BACKGROUND: Renal cell carcinoma (RCC) is one of the most common kidney cancers and is highly resistant to chemotherapy. Accumulating evidence suggests that interleukin-22 (IL-22) may mediate host defense against varietal pathogens as a proinflammatory and anti-inflammatory cytokine. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fengbo, Shang, Donghao, Zhang, Yuhai, Tian, Ye
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100322/
https://www.ncbi.nlm.nih.gov/pubmed/21625390
http://dx.doi.org/10.1371/journal.pone.0020382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100322/
https://www.ncbi.nlm.nih.gov/pubmed/21625390
http://dx.doi.org/10.1371/journal.pone.0020382

Ejemplares similares